Now on ScienceBlogs: Science Ahead of Its Time?
"A statement of fact cannot be insolent." The miscellaneous ramblings of a surgeon/scientist on medicine, quackery, science, pseudoscience, history, and pseudohistory (and anything else that interests him)
Orac is the nom de blog of a (not so) humble pseudonymous surgeon/scientist with an ego just big enough to delude himself that someone, somewhere might actually give a rodent's posterior about his miscellaneous verbal meanderings, but just barely small enough to admit to himself that few will. (Continued here, along with a DISCLAIMER that you should read before reading any medical discussions here.)
Orac's old Blog is archived at Archived Insolence.
« Who's the stupidest Holocaust denier of them all? | Main | Doctor Strange: The only way to make homeopathy work »
Category: Medicine • Personal
Posted on: May 20, 2007 3:15 AM, by Orac
Abel Pharmboy shows why I shouldn't have left my American Society of Clinical Oncology (ASCO) proceedings abstract sit on my desk unread for a week.
Damn. Talk about blowing an opportunity. Of course, given that I don't own any pharmaceutical stocks (making me a rather poor "tool of big pharma" indeed), it doesn't matter.
Share this: Facebook Twitter Stumbleupon Reddit Email + More
PZ Myers 11.24.2009
PZ Myers 11.24.2009
Orac 11.25.2009
Tim Lambert 11.22.2009
Ed Brayton 11.24.2009
Comments
Since most of them went down it doesn't appear to be such a good prognosticator for cancer patients. If one knew much about which trials are done and ready to be reported on just knowing who went up and who went down would be a clue.
But Pharmboy has a point about insider information. Let's lock them all up like Martha Stewart!
At one point in my less than stellar investment experience I had hope that owning big pharm would help me afford their wares in my old age! These days I can only hope that some suffering factory worked in Southeast Asia will be my salvation.
Posted by: AnnR | May 20, 2007 1:36 PM